These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38365702)

  • 1. Phage vB_Ec_ZCEC14 to treat antibiotic-resistant Escherichia coli isolated from urinary tract infections.
    Ismael NM; Azzam M; Abdelmoteleb M; El-Shibiny A
    Virol J; 2024 Feb; 21(1):44. PubMed ID: 38365702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi-drug resistant and extensively drug-resistant biofilm-forming uropathogenic Escherichia coli isolates, India.
    Chaudhary N; Mohan B; Mavuduru RS; Kumar Y; Taneja N
    J Appl Microbiol; 2022 Apr; 132(4):3387-3404. PubMed ID: 34989075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
    Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
    Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and synergy studies of Caudoviricete Escherichia phage FS2B infecting multi-drug resistant uropathogenic Escherichia coli isolates.
    Malik S; Nehra K; Mann A; Jagdish R; Rana JS
    Int Microbiol; 2024 Feb; 27(1):155-166. PubMed ID: 37247084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.
    González-Villalobos E; Ribas-Aparicio RM; Montealegre GER; Belmont-Monroy L; Ortega-García Y; Aparicio-Ozores G; Balcázar JL; Eslava-Campos CA; Hernández-Chiñas U; Molina-López J
    Appl Microbiol Biotechnol; 2021 Jul; 105(13):5617-5629. PubMed ID: 34254156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.
    Zulk JJ; Clark JR; Ottinger S; Ballard MB; Mejia ME; Mercado-Evans V; Heckmann ER; Sanchez BC; Trautner BW; Maresso AW; Patras KA
    mSphere; 2022 Aug; 7(4):e0034522. PubMed ID: 35920561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutics and prophylactic efficacy of novel lytic Escherichia phage vB_EcoS_PJ16 against multidrug-resistant avian pathogenic E. coli using in vivo study.
    Jhandai P; Mittal D; Gupta R; Kumar M; Khurana R
    Int Microbiol; 2024 Jun; 27(3):673-687. PubMed ID: 37632591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophage therapy for
    Bhargava K; Nath G; Dhameja N; Kumar R; Aseri GK; Jain N
    Future Microbiol; 2023 Apr; 18():323-334. PubMed ID: 37140267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of bacteriophages infecting multidrug-resistant uropathogenic Escherichia coli strains.
    Markusková B; Elnwrani S; Andrezál M; Sedláčková T; Szemes T; Slobodníková L; Kajsik M; Drahovská H
    Arch Virol; 2024 Jun; 169(7):142. PubMed ID: 38851653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Analysis of a Novel Phage Infecting the Turkey Pathogen
    Deng S; Xu Q; Fu Y; Liang L; Wu Y; Peng F; Gao M
    Viruses; 2021 May; 13(6):. PubMed ID: 34072620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
    Malik S; Nehra K; Rana JS
    Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study.
    Ramírez-Castillo FY; Moreno-Flores AC; Avelar-González FJ; Márquez-Díaz F; Harel J; Guerrero-Barrera AL
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):34. PubMed ID: 30041652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation, Characterization and Genomic Analysis of a Novel Bacteriophage VB_EcoS-Golestan Infecting Multidrug-Resistant Escherichia coli Isolated from Urinary Tract Infection.
    Yazdi M; Bouzari M; Ghaemi EA; Shahin K
    Sci Rep; 2020 May; 10(1):7690. PubMed ID: 32376832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lytic phage to control multidrug-resistant avian pathogenic
    Yao L; Bao Y; Hu J; Zhang B; Wang Z; Wang X; Guo W; Wang D; Qi J; Tian M; Bao Y; Li H; Wang S
    Front Cell Infect Microbiol; 2023; 13():1253815. PubMed ID: 37743864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic
    Slobodníková L; Markusková B; Kajsík M; Andrezál M; Straka M; Liptáková A; Drahovská H
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of two bacteriophages with lytic activity against multidrug-resistant Escherichia coli.
    Fu P; Zhao Q; Shi L; Xiong Q; Ren Z; Xu H; Chai S; Xu Q; Sun X; Sang M
    Virus Res; 2021 Jan; 291():198196. PubMed ID: 33098914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel bacteriophage vB_EcoP-EG1 with lytic activity against planktonic and biofilm forms of uropathogenic Escherichia coli.
    Gu Y; Xu Y; Xu J; Yu X; Huang X; Liu G; Liu X
    Appl Microbiol Biotechnol; 2019 Jan; 103(1):315-326. PubMed ID: 30397766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel phages, Klebsiella phage GADU21 and Escherichia phage GADU22, from the urine samples of patients with urinary tract infection.
    Salih Doğan H; Karaynir A; Yilmaz Üİ; Başgöz BB; Hoşbul T; Bozdoğan B
    Virus Genes; 2024 Apr; 60(2):208-221. PubMed ID: 38238612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Phage Cocktail Therapy of the Urinary Tract Infection in a Mouse Model.
    Mijbel Ali B; Gatea Kaabi SA; Al-Bayati MA; Musafer HK
    Arch Razi Inst; 2021 Nov; 76(5):1229-1236. PubMed ID: 35355758
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral Resistance and Phage Counter Adaptation to Antibiotic-Resistant Extraintestinal Pathogenic
    Salazar KC; Ma L; Green SI; Zulk JJ; Trautner BW; Ramig RF; Clark JR; Terwilliger AL; Maresso AW
    mBio; 2021 Apr; 12(2):. PubMed ID: 33906920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.